For the Chicago Bears, the 2024 season began as one of the most optimistic campaigns in recent history. The team was expected to threaten for a playoff berth af ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

Prophet Johnson scored 15 points as Fairfield beat Manhattan 87-84 in overtime on Thursday night. Johnson also contributed 11 rebounds and three steals for the Stags (8-11, 4-4 Metro Atlantic Athletic ...

Jalen Johnson was listed as probable coming into tonight's game vs Toronto, but he has been cleared to play, as has Trae Young. Coming into tonight's game, the ...

DUNKIRK — Micah Johnson, Nolan Wilczewski and Landon Johnson won two individual events each to pace the Olean High boys swimming and diving team to a win over Dunkirk on ...

"We are all just hurting, grieving our sister and praying for her baby boy's recovery," said a sobbing Shanika Johnson.

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Stifel analyst Rick Wise lowered the firm’s price target on Johnson & Johnson to $155 from $170 and keeps a Hold rating on the shares.

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. But shares slipped 3.2% to $143.35 in Wednesday morning trading, ...

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...

J&J’s 2025 results will be the launching point for its guidance of 5%-7% revenue growth for 2025-30, which is still well ...